<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03401489</url>
  </required_header>
  <id_info>
    <org_study_id>Pro00070627</org_study_id>
    <nct_id>NCT03401489</nct_id>
  </id_info>
  <brief_title>PACESETTER: Program to Avoid Cerebrovascular Events Through Systematic Electronic Tracking and Tailoring of an Eminent Risk-factor</brief_title>
  <official_title>Program to Avoid Cerebrovascular Events Through Systematic Electronic Tracking and Tailoring of an Eminent Risk-factor</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northern California Institute of Research and Education</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Prisma Health-Upstate</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Northern California Institute of Research and Education</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Program to Avoid Cerebrovascular Events through Systematic Electronic Tracking and Tailoring
      of an Eminent Risk-factor (PACESETTER) aims to assess the incorporation of its stroke
      intervention into all 3 safety net/academic health sytems in a given US state especially
      burdened by stroke, thereby enhancing knowledge about the complexity of stroke interventions,
      and especially the nature of the challenges encountered in low resource settings and for
      populations traditionally underrepresented in research. Altogether, the intervention, if
      proven implementable and effective, may eventually be exported to other medically underserved
      populations in the US beyond SC as a feasible model of post-stroke management.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">June 2020</start_date>
  <completion_date type="Anticipated">January 2025</completion_date>
  <primary_completion_date type="Anticipated">June 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Systolic BP</measure>
    <time_frame>12 months</time_frame>
    <description>Systolic blood pressure</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Longitudinal Comparisons of BP</measure>
    <time_frame>12 montjhs</time_frame>
    <description>comparison between intervention and control group</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Blood Pressure</condition>
  <condition>Hypertension</condition>
  <condition>Mhealth</condition>
  <arm_group>
    <arm_group_label>PACESETTER</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy Lifestyle Intervention Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PACESETTER</intervention_name>
    <description>Patients will be given a Viaca electronic pill tray &amp; blue-toothed UA-767 Plus BT BP device and the PACESETTER app installed on their smart phone for automatic relay of BP data. The Vaica tray emits a blinking light for 30 minutes when it is time to take the meds. If the compartment is not opened and emptied, an intermittent chime ensues for 30 minutes. If the compartment is not opened and emptied, the subject /caregiver receives an automated SMS or email. PACESETTERs will be given a questionnaire. Responses will be used to generate personalized motivational &amp; reinforcement messages guided by self-determination theory constructs of competence &amp; autonomous regulation. In addition, PACESETTERs will receive 30-45 second auditory or text messages 2 times per week on HTN/stroke facts, importance of med adherence, tips on expressing questions/concerns with physician. We will calculate medication possession ratios, on all subjects' HTN medications at each evaluation.</description>
    <arm_group_label>PACESETTER</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  recent history of stroke (within one month of symptom onset)

          -  uncontrolled HTN (SBP ≥ 140 &amp;/or DBP ≥ 90 mmHg at the last clinical encounter
             post-stroke prior to recruitment).

        Exclusion Criteria:

          -  Any condition that would limit participation in follow up assessments, severe
             cognitive impairment/dementia (MMSE ≤24)

          -  severe global disability (modified Rankin Score ≥ 3)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Bruce Ovbiagele, MD</last_name>
    <phone>415-221-4810</phone>
    <phone_ext>25327</phone_ext>
    <email>bruce.ovbiagele@va.gov</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Raelle Tagge, MPH</last_name>
    <email>raelle.tagge@ncire.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>NCIRE</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94121</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Raelle Tagge, MPH</last_name>
      <email>raelle.tagge@ncire.org</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Palmetto Health</name>
      <address>
        <city>Columbia</city>
        <state>South Carolina</state>
        <zip>29203</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Brittiny McMillian</last_name>
      <email>brittiny.mcmillian@uscmed.sc.edu</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Greenville Health Systems</name>
      <address>
        <city>Greenville</city>
        <state>South Carolina</state>
        <zip>29615</zip>
        <country>United States</country>
      </address>
    </facility>
    <contact>
      <last_name>Tory Holt</last_name>
      <email>Tory.Holt@prismahealth.org</email>
    </contact>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>January 10, 2018</study_first_submitted>
  <study_first_submitted_qc>January 10, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 17, 2018</study_first_posted>
  <last_update_submitted>May 20, 2020</last_update_submitted>
  <last_update_submitted_qc>May 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northern California Institute of Research and Education</investigator_affiliation>
    <investigator_full_name>Bruce Ovbiagele</investigator_full_name>
    <investigator_title>Chief of Staff</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

